NASDAQ NMS - GLOBAL MARKET · IVVD
+10.85% · +$0.0656 · Vol 3.3M
After hours · updated 19:08:42 ET
Invivyd Inc

Invivyd Inc

Biotechnology
$0.6700
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
IVVD
Invivyd Inc
Thu Aug 6 · session closed · Markets closed · resumes Fri 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Thu Aug 6 · session closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IVVD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IVVD catalysts
About Invivyd Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
122
Country
US

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6102
Day high
$0.6701
Day low
$0.6088
Previous close
$0.6044
52W high
$2.88
-76.74% from high
52W low
$0.5201
6% of range
Market cap
$178.1M
EPS
$-0.4500
Beta
1.93
Shares out
294.6M
Volume
3.3M
0.78× rel vol
Avg volume
4.2M
VWAP
$0.6488
Price history computed in-house
1W
+15.20%
1M
-28.86%
3M
-55.33%
1Y
-6.56%
YTD
-72.87%
SMA 50 $0.8372 · below
SMA 200 $1.60 · below
52W position 6%

IVVD overview

Veridion Score
49
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IVVD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IVVD Form 4 filings
Public disclosures

Congress activity in IVVD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IVVD in the cached public ledger.

Federal contracts

IVVD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IVVD in this window.
Lobbying spend

IVVD lobbying filings, year to date.

Registered lobbying filings matched to Invivyd Inc.

$280.0K
Refresh interval: 12hSource: LDA disclosure filings
Health IssuesManufacturing Health Issues
Filing
$120.0K
INVIVYD

FORBES-TATE

Jul 20, 2026
Filing
$60.0K
INVIVYD INC.

INVIVYD, INC.

Jun 24, 2026
Filing
$60.0K
INVIVYD

FORBES-TATE

Apr 20, 2026
Loading news for IVVD
Analyst ratings
Sovereign unlock shows live analyst consensus for IVVD.
Options
Sovereign unlock shows live options positioning for IVVD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.